[Better therapeutic potential for azathioprine and mercaptopurine].
Bergan
S
S
Norge
O
O
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects; D001379:Azathioprine / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D002648:Child; D005838:Genotype; D006801:Humans; D015122:Mercaptopurine / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D008780:Methyltransferases / Q000235:genetics; D010641:Phenotype; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy
D000964:Antimetabolites, Antineoplastic; D015122:Mercaptopurine; D008780:Methyltransferases; D001379:Azathioprine